The world of psychedelic medicine is transforming mental health treatment and we welcome Dave Muise, VP of Business Development at NuVista Psychedelic Medicine, to help us understand what their company is out to accomplish. Dave shares insights into how ketamine is now being harnessed to combat PTSD, depression, and anxiety, particularly when these conditions stem from trauma. Send us a text Support the showFind The Afternoon Pint on Youtube Facebook Instagram & TikTok Buy merch, get out newsletter, or book some of Afternoon Pints Media Talent on our website: www.afternoonpint.ca #afternoonpint #entrepreneur #popculture #authors #actors #politics #money #music #popular #movies #canadalife #madeincanada Your follows likes and subscribes help support Canadian Made Media. Please drop us a line and let us know if you are enjoying the show.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 11PM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 10PM EST
08 Dec 2025
NPR News Now
Meidas Health: AAP President Strongly Pushes Back on Hepatitis B Vaccine Changes
08 Dec 2025
The MeidasTouch Podcast
Democrat Bobby Cole Discusses Race for Texas Governor
07 Dec 2025
The MeidasTouch Podcast
Fox News Crashes Out on Air Over Trump’s Rapid Fall
07 Dec 2025
The MeidasTouch Podcast